null Susan Bartlett, PhD
behavioural medicine • inflammatory arthritis • patient-centred outcomes • patient research partners • psychosocial factors
My research focuses on behavioural factors that affect health outcomes. I study how behaviour change (e.g., diet, exercise, smoking, taking medications regularly) and emotional wellbeing (stress, depression, anxiety) can help people with inflammatory arthritis and other chronic conditions feel and function better. I also evaluate ways to make medical care more patient-centred by collaborating with patient research partners, developing better patient reported outcome measures, and improving doctor-patient communication.
Hazlewood GS, Loyola-Sanchez A, Bykerk V, Hull PM, Marshall D, Pham T, Barber CEH, Barnabe C, Sirois A, Pope J, Schieir O, Richards D, Proulx L, Bartlett SJ. Patient and rheumatologist perspectives on tapering dmards in rheumatoid arthritis: A qualitative study. Rheumatology. 2021. Epub 2021/04/21. doi: 10.1093/rheumatology/keab330. PMID: 33878168.
Bartlett SJ, Gutierrez AK, Andersen KM, Bykerk VP, Curtis JR, Haque UJ, Orbai AM, Jones MR, Bingham CO, 3rd. Identifying minimal and meaningful change in promis(®) for rheumatoid arthritis: Use of multiple methods and perspectives. Arthritis Care Res (Hoboken). 2020. Epub 2020/11/10. doi: 10.1002/acr.24501. PMID: 33166066.
Ahmed S, Barbera L, Bartlett SJ, Bebb DG, Brundage M, Bryan S, Cheung WY, Coburn N, Crump T, Cuthbertson L, Howell D, Klassen AF, Leduc S, Li M, Mayo NE, McKinnon G, Olson R, Pink J, Robinson JW, Santana MJ, Sawatzky R, Moxam RS, Sinclair S, Servidio-Italiano F, Temple W. A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes. Curr Oncol. 2020;27(2):90-9. PubMed PMID: 32489251.
Bartlett SJ, Lambert SD, McCusker J, Yaffe M, de Raad M, Belzile E, Ciampi A, Di Carlo M, Lyddiatt A. Self-management across chronic diseases: Targeting education and support needs. Patient Educ Couns. 2020;103(2):398-404. PMID: 31575442.
Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO, 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck AC, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS. Improving benefit-harm assessment of therapies from the patient perspective: Omeract premeeting toward consensus on core sets for randomized controlled trials. J Rheumatol. 2019;46(8):1053-8. PMID: 30647191.